Key statistics
On Monday, Bio-Techne Corp (TECH:NSQ) closed at 65.48, -9.26% below its 52-week high of 72.16, set on Jan 22, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 66.07 |
|---|---|
| High | 66.51 |
| Low | 64.52 |
| Bid | 65.44 |
| Offer | 67.36 |
| Previous close | 66.78 |
| Average volume | 2.76m |
|---|---|
| Shares outstanding | 156.45m |
| Free float | 156.01m |
| P/E (TTM) | 129.01 |
| Market cap | 10.24bn USD |
| EPS (TTM) | 0.5076 USD |
| Annual div (ADY) | 0.32 USD |
|---|---|
| Annual div yield (ADY) | 0.48% |
| Div ex-date | Nov 17 2025 |
| Div pay-date | Nov 28 2025 |
| Next div ex-date | Feb 13 2026 |
| Next div pay-date | Feb 27 2026 |
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
- Bio-Techne Declares Dividend
- Bio-Techne Releases Second Quarter Fiscal 2026 Results
- Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
- Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers
- Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
- Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
- Bio-Techne Partners with the Wyss Center Geneva to Advance Automated 3D Multiomics Technology and Accelerate Spatial Biology
- Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis
- Bio-Techne to Present at Upcoming Investor Conferences
- Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
More ▼
